3739(E)_Notification of Medical Devices Testing Officer for CMDTLĢ022.06.30_Final GSR 502(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs RulesĢ022.06.15_Final GSR 450(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDRĢ2.06.14_Draft_GSR 448(E)_Amendment in rule 96 for mandating Bar code or QR code on the label of top 300 brand in Drugs RulesĢ022.05.25_Draft_GSR 393(E)_Exemption under Schedule K of the Drugs Rules, 1945 for OTC drugsĢ022.05.23_Draft GSR 382(E)_Parallel submission in Form 28-DĢ022.05.23_Draft GSR 383(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs RulesĢ022.05.18_Final GSR 357(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945Ģ022.05.18_Final GSR 356(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017Ģ022.03.29_Draft GSR 228(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDRĢ022.03.29_Draft GSR 227(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945Ģ022.03.04_Final GSR 174(E)_Amendment of rule 36(3) MDR to include United Kingdom under MDR,2017Ģ022.02.24_Final GSR 158(E)_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945Ģ022.02.24_Final GSR 158_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945Ģ022.02.09_S.O. 3758(E)_To authorize director incharge of CDL Kolkata for signing report of test of MD samples sent by Court of MD samples sent by Court of Laws.Įxtract of the New Drugs and Clinical Trials Rules 2019 relevant to Ethics Committee for Clinical Trial, Bioavailability and Bioequivalence studyĢ022.08.02_S.O.
3757(E)_Notification of Director Incharge of CDL KolkataĢ022.08.10_Final GSR 623(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945.Ģ022.08.10_S.O. 4574(E)_Designation of Government Analysts at RDTL Chandigarh as MDTO as per MDR 2017Ģ022.09.28_S.O._4573(E)_Notification for designation of RDTL Chandigarh also as CMDTL as per MDR 2017Ģ022.09.20_Draft_GSR 710(E)_Exemption of certain Class A medical device from licensing regimeĢ022.08.24_Final GSR 654(E)_Parallel submission in Form 28-DĢ022.08.10_S.O.
0 kommentar(er)
